Qiagen NV | QIA - 营业费用

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.27B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	营业费用	更改		日
Akebia Therapeutics	USD 63.08M		8.26M	2025-12
Alaunos Therapeutics	USD 1.01M		175K	2026-03
argenx SE	USD 1.02B		118M	2026-06
Avita Medical	AUD 28.02M		1.55M	2025-12
Dianthus Therapeutics	USD 47M		22.83M	2026-03
Ionis Pharmaceuticals	USD 370.24M		6.24M	2026-06
IQVIA Holdings	USD 1.77B		4.45B	2026-06
Moderna	USD 960M		817M	2026-06
Organon & Co	USD 1.01B		103M	2026-06
Qiagen NV	USD 393.64M		17.95M	2026-06
Revvity	USD 603.55M		24.8M	2026-06
Tectonic Therapeutic	USD 27.3M		5.78M	2026-03
Viatris	USD 3.68B		145.9M	2026-06
Xeris Pharmaceuticals	USD 75.21M		6.18M	2026-03